$KE

Kimball Electronics, Inc.

Kimball Electronics provides contract manufacturing services to automotive, medical, and industrial customers, producing products to their specifications. Its offerings combine electronics manufacturing services with contract development and manufacturing organization solutions through the Kimball Solutions platform. Services include printed circuit board assembly and testing, higher-level and final assembly, design and engineering support, supply chain services, prototyping, product validation, reliability testing, aftermarket services, medical disposables, drug delivery devices, precision molded plastics, clean room assembly, and product lifecycle support. Kimball makes money by providing these services on a contract basis. Kimball operates one reportable segment and serves customers through manufacturing facilities in the United States, China, India, Mexico, The Netherlands, Poland, Romania, and Thailand. Its corporate headquarters is in Jasper, Indiana.

2
1
2

No SEC Form 4 filings for $KE in the last 30 days.

See all $KE insider activity →
Low

Buy, Sell, or Hold? Thursday’s Top Upgrades and Downgrades: Advanced Micro Devices, Alibaba Group, Cleveland-Cliffs, Conoco Phillips, Diamondback Energy, General Mills, NVIDIA, Toyota, Wendy’s and Mor

Stock futures are mixed after a strong Wednesday. Analysts upgraded AMD, Alibaba (BABA), Cleveland-Cliffs (CLF), Reliance Steel (RS), and Wendy's (WEN). Downgrades include Conoco Phillips (COP), Diamondback Energy (FANG), General Mills (GIS), NVIDIA (NVDA), and Toyota (TM). New coverage was initiated for Agility Robotics (AGLT), Cars.com (CARS), Dorman Products (DORM), Kimball Electronics (KE), and Quantinuum (QNT).

KE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 5 news stories mentioning KE (Kimball Electronics, Inc.). Coverage has been balanced: 2 bullish, 1 neutral, and 2 bearish.

Recent KE coverage spans earnings and financial news.

What's driving KE

AlphAI scores every news story that mentions KE with an AI model for sentiment and relevance, and aggregates insider trades from Kimball Electronics, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $KE

Score

Buy, Sell, or Hold? Thursday’s Top Upgrades and Downgrades: Advanced Micro Devices, Alibaba Group, Cleveland-Cliffs, Conoco Phillips, Diamondback Energy, General Mills, NVIDIA, Toyota, Wendy’s and Mor

Stock futures are mixed after a strong Wednesday. Analysts upgraded AMD, Alibaba (BABA), Cleveland-Cliffs (CLF), Reliance Steel (RS), and Wendy's (WEN). Downgrades include Conoco Phillips (COP), Diamondback Energy (FANG), General Mills (GIS), NVIDIA (NVDA), and Toyota (TM). New coverage was initiated for Agility Robotics (AGLT), Cars.com (CARS), Dorman Products (DORM), Kimball Electronics (KE), and Quantinuum (QNT).

KIMBALL ELECTRONICS REPORTS Q1 RESULTS HIGHLIGHTED BY THE RETURN TO TOP-LINE GROWTH; COMPANY REITERATES GUIDANCE FOR FISCAL 2027 WITH SALES EXPECTED AT THE…

Kimball Electronics, Inc. (KE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 KIMBALL ELECTRONICS REPORTS Q1 RESULTS HIGHLIGHTED BY THE RETURN TO TOP-LINE GROWTH; COMPANY REITERATES GUIDANCE FOR FISCAL 2027 WITH SALES EXPECTED AT THE HIGH END OF THE RANGE JASPER, Ind., November 4, 2026 -- (BUSINESS WIRE) -- Kimball Electronics, Inc. (Nasdaq: K

Kimball Electronics (KE) Bets Big On Medical Devices And Debt Paydown

Kimball Electronics (KE) reported Q4 net sales of $371.6M, up 5% sequentially. Full-year sales fell 4% to $1.431B. The company expects fiscal 2027 sales of $1.535B-$1.56B, driven by medical device growth and a recent acquisition. Debt reduced to $116.6M, with $88.9M in cash. Guidance includes flat to lower margins despite higher capital spending.

Should You Buy Kimball Electronics Stock After Lackluster Q4 Results?

Kimball Electronics (KE) reported Q4 fiscal 2026 earnings of -$0.01 per share, missing estimates, with revenue down 2.3% YoY. Medical revenues grew 1%, while Automotive and Industrial declined. Despite the weak quarter, management expects fiscal 2027 revenue growth of 7-9%, driven by Medical market expansion and recent acquisitions. KE stock has underperformed peers over the past year.

Related tickers